Skip to main content
. 2021 Jun 5;71(1):203–217. doi: 10.1007/s00262-021-02979-4

Fig. 1.

Fig. 1

Progression-free survival after nivolumab therapy according to serum lipid levels: part 1. Low-density lipoprotein (LDL) cholesterol (a), lauric acid (b), myristic acid (c), oleic acid (d), eicosadienoic acid (e), and docosatetraenoic acid (f). Three concentration categories were created for each lipid: low (less than the interquartile range [IQR], blue line), intermediate (within the IQR, green line), and high (higher than the IQR, red line)